Methyl-CCNU for patients with previously treated metastatic neuroblastoma--a phase II study.
D002648:Child; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D009362:Neoplasm Metastasis; D009447:Neuroblastoma / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D012673:Semustine / Q000009:adverse effects / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced
D009607:Nitrosourea Compounds; D012673:Semustine